Filed: 2/14/2025ACC: 0001214659-25-002812
📋 What this filing means
TANG CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 183 equity positions with a total reported market value of $1.51B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
183
Positions
$1.51B
Total AUM (reported)
172.12M
Total Shares
Allocation by class
COM$1.09B71.8%
COM NEW$112.63M7.5%
SPON ADR$59.43M3.9%
SPONSORED ADS$51.28M3.4%
ADS$45.89M3.0%
SPONSORED ADR$43.21M2.9%
COM CL A$19.47M1.3%
Portfolio Concentration
Top 3$259.98M17.2%
4–10$307.39M20.3%
11–25$329.28M21.8%
Rest$614.68M40.7%
Top 3 weight
17.2%
Top 10 weight
37.5%
Voting Authority Distribution
Total shares with voting rights: 172.12M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
172.12M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other183
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings183
Rows:
TARSUS PHARMACEUTICALS INC
OTRShares2.25M
TypeSH
Market value$124.85M
8.26%
Sole
0.00
Shared
2.25M
None
0.00
AURINIA PHARMACEUTICALS INC
OTRShares8.43M
TypeSH
Market value$75.70M
5.01%
Sole
0.00
Shared
8.43M
None
0.00
GALAPAGOS NV
OTRShares2.16M
TypeSH
Market value$59.43M
3.93%
Sole
0.00
Shared
2.16M
None
0.00
EVOLUS INC
OTRShares5M
TypeSH
Market value$55.17M
3.65%
Sole
0.00
Shared
5M
None
0.00
MIRUM PHARMACEUTICALS INC
OTRShares1.24M
TypeSH
Market value$51.15M
3.38%
Sole
0.00
Shared
1.24M
None
0.00
VIRIDIAN THERAPEUTICS INC
OTRShares2.49M
TypeSH
Market value$47.79M
3.16%
Sole
0.00
Shared
2.49M
None
0.00
IMMUNOCORE HLDGS PLC
OTRShares1.56M
TypeSH
Market value$45.89M
3.04%
Sole
0.00
Shared
1.56M
None
0.00
KALVISTA PHARMACEUTICALS INC
OTRShares4.89M
TypeSH
Market value$41.45M
2.74%
Sole
0.00
Shared
4.89M
None
0.00
RELAY THERAPEUTICS INC
OTRShares8.07M
TypeSH
Market value$33.24M
2.20%
Sole
0.00
Shared
8.07M
None
0.00
REPLIMUNE GROUP INC
OTRShares2.70M
TypeSH
Market value$32.70M
2.16%
Sole
0.00
Shared
2.70M
None
0.00
PTC THERAPEUTICS INC
OTRShares700K
TypeSH
Market value$31.60M
2.09%
Sole
0.00
Shared
700K
None
0.00
BIONTECH SE
OTRShares270K
TypeSH
Market value$30.77M
2.04%
Sole
0.00
Shared
270K
None
0.00
ACADIA PHARMACEUTICALS INC
OTRShares1.50M
TypeSH
Market value$27.52M
1.82%
Sole
0.00
Shared
1.50M
None
0.00
INTRA-CELLULAR THERAPIES INC
OTRShares300K
TypeSH
Market value$25.06M
1.66%
Sole
0.00
Shared
300K
None
0.00
VAXCYTE INC
OTRShares300K
TypeSH
Market value$24.56M
1.62%
Sole
0.00
Shared
300K
None
0.00
DYNAVAX TECHNOLOGIES CORP
OTRShares1.85M
TypeSH
Market value$23.62M
1.56%
Sole
0.00
Shared
1.85M
None
0.00
LENZ THERAPEUTICS INC
OTRShares766.94K
TypeSH
Market value$22.14M
1.47%
Sole
0.00
Shared
766.94K
None
0.00
NEUROCRINE BIOSCIENCES INC
OTRShares150K
TypeSH
Market value$20.48M
1.35%
Sole
0.00
Shared
150K
None
0.00
ALTIMMUNE INC
OTRShares2.75M
TypeSH
Market value$19.83M
1.31%
Sole
0.00
Shared
2.75M
None
0.00
NVIDIA CORPORATION
OTRShares142.57K
TypeSH
Market value$19.15M
1.27%
Sole
0.00
Shared
142.57K
None
0.00
ANAPTYSBIO INC
OTRShares1.33M
TypeSH
Market value$17.62M
1.17%
Sole
0.00
Shared
1.33M
None
0.00
ANI PHARMACEUTICALS INC
OTRShares317.50K
TypeSH
Market value$17.55M
1.16%
Sole
0.00
Shared
317.50K
None
0.00
JAZZ PHARMACEUTICALS PLC
OTRShares140K
TypeSH
Market value$17.24M
1.14%
Sole
0.00
Shared
140K
None
0.00
ZYMEWORKS INC
OTRShares1.10M
TypeSH
Market value$16.10M
1.07%
Sole
0.00
Shared
1.10M
None
0.00
ATEA PHARMACEUTICALS INC
OTRShares4.79M
TypeSH
Market value$16.04M
1.06%
Sole
0.00
Shared
4.79M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
TARSUS PHARMACEUTICALS INCOTR | COM | 2.25M | SH | $124.85M 8.26% | 0.00 | 2.25M | 0.00 |
AURINIA PHARMACEUTICALS INCOTR | COM | 8.43M | SH | $75.70M 5.01% | 0.00 | 8.43M | 0.00 |
GALAPAGOS NVOTR | SPON ADR | 2.16M | SH | $59.43M 3.93% | 0.00 | 2.16M | 0.00 |
EVOLUS INCOTR | COM | 5M | SH | $55.17M 3.65% | 0.00 | 5M | 0.00 |
MIRUM PHARMACEUTICALS INCOTR | COM | 1.24M | SH | $51.15M 3.38% | 0.00 | 1.24M | 0.00 |
VIRIDIAN THERAPEUTICS INCOTR | COM | 2.49M | SH | $47.79M 3.16% | 0.00 | 2.49M | 0.00 |
IMMUNOCORE HLDGS PLCOTR | ADS | 1.56M | SH | $45.89M 3.04% | 0.00 | 1.56M | 0.00 |
KALVISTA PHARMACEUTICALS INCOTR | COM | 4.89M | SH | $41.45M 2.74% | 0.00 | 4.89M | 0.00 |
RELAY THERAPEUTICS INCOTR | COM | 8.07M | SH | $33.24M 2.20% | 0.00 | 8.07M | 0.00 |
REPLIMUNE GROUP INCOTR | COM | 2.70M | SH | $32.70M 2.16% | 0.00 | 2.70M | 0.00 |
PTC THERAPEUTICS INCOTR | COM | 700K | SH | $31.60M 2.09% | 0.00 | 700K | 0.00 |
BIONTECH SEOTR | SPONSORED ADS | 270K | SH | $30.77M 2.04% | 0.00 | 270K | 0.00 |
ACADIA PHARMACEUTICALS INCOTR | COM | 1.50M | SH | $27.52M 1.82% | 0.00 | 1.50M | 0.00 |
INTRA-CELLULAR THERAPIES INCOTR | COM | 300K | SH | $25.06M 1.66% | 0.00 | 300K | 0.00 |
VAXCYTE INCOTR | COM | 300K | SH | $24.56M 1.62% | 0.00 | 300K | 0.00 |
DYNAVAX TECHNOLOGIES CORPOTR | COM NEW | 1.85M | SH | $23.62M 1.56% | 0.00 | 1.85M | 0.00 |
LENZ THERAPEUTICS INCOTR | COM | 766.94K | SH | $22.14M 1.47% | 0.00 | 766.94K | 0.00 |
NEUROCRINE BIOSCIENCES INCOTR | COM | 150K | SH | $20.48M 1.35% | 0.00 | 150K | 0.00 |
ALTIMMUNE INCOTR | COM NEW | 2.75M | SH | $19.83M 1.31% | 0.00 | 2.75M | 0.00 |
NVIDIA CORPORATIONOTR | COM | 142.57K | SH | $19.15M 1.27% | 0.00 | 142.57K | 0.00 |
ANAPTYSBIO INCOTR | COM | 1.33M | SH | $17.62M 1.17% | 0.00 | 1.33M | 0.00 |
ANI PHARMACEUTICALS INCOTR | COM | 317.50K | SH | $17.55M 1.16% | 0.00 | 317.50K | 0.00 |
JAZZ PHARMACEUTICALS PLCOTR | SHS USD | 140K | SH | $17.24M 1.14% | 0.00 | 140K | 0.00 |
ZYMEWORKS INCOTR | COM | 1.10M | SH | $16.10M 1.07% | 0.00 | 1.10M | 0.00 |
ATEA PHARMACEUTICALS INCOTR | COM | 4.79M | SH | $16.04M 1.06% | 0.00 | 4.79M | 0.00 |
Page 1 of 8
…